Source:http://linkedlifedata.com/resource/pubmed/id/17095085
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-12-1
|
pubmed:abstractText |
Considerable research has been focused on the development of bone morphogenetic protein-2 (BMP-2) delivery system for homologous and efficient bone regeneration. The aim of the present study was to develop a collagen-based targeting bone repair system. A collagen-binding domain (CBD) was added to the N-terminal of native BMP-2 to allow it bind to collagen specifically. We showed that the collagen-binding bone morphogenetic protein-2 (named bone morphogenetic protein2-h, BMP2-h) had maintained the full biological activity as compared to rhBMP2 lacking the CBD. In vitro functional study also demonstrated that collagen matrix could maintain higher bioactivity of BMP2-h than native BMP-2. When demineralized bone matrix (DBM) impregnated with BMP2-h was implanted subcutaneously in rats, homogeneous bone formation was observed. Moreover, in a rabbit mandible defect model, surgical implantation of collagen matrix loaded with BMP2-h exhibited remarkable osteoinductive properties and excellent homogeneous bone formation. Our studies suggested that this novel collagen-based BMP-2 targeting bone repair system induced better bone formation not only in quantity but also in quality. Similar approaches may also be used for the repair of other tissue injuries.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bmp7 protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 7,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0142-9612
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1027-35
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17095085-Animals,
pubmed-meshheading:17095085-Bone Demineralization Technique,
pubmed-meshheading:17095085-Bone Matrix,
pubmed-meshheading:17095085-Bone Morphogenetic Protein 7,
pubmed-meshheading:17095085-Bone Morphogenetic Proteins,
pubmed-meshheading:17095085-Bone Regeneration,
pubmed-meshheading:17095085-Collagen,
pubmed-meshheading:17095085-Drug Carriers,
pubmed-meshheading:17095085-Fracture Healing,
pubmed-meshheading:17095085-Male,
pubmed-meshheading:17095085-Mandibular Fractures,
pubmed-meshheading:17095085-Osteogenesis,
pubmed-meshheading:17095085-Rabbits,
pubmed-meshheading:17095085-Rats,
pubmed-meshheading:17095085-Rats, Wistar,
pubmed-meshheading:17095085-Transforming Growth Factor beta,
pubmed-meshheading:17095085-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2.
|
pubmed:affiliation |
Key Laboratory of Molecular and Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 3 Nanyitiao, Zhongguancun, Beijing 100080, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|